195 related articles for article (PubMed ID: 6136952)
1. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
Helman CA; Tim LO
Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
[TBL] [Abstract][Full Text] [Related]
2. Ranitidine--pharmacology and clinical use.
Dawson J; Richards DA; Stables R; Dixon GT; Cockel R
J Clin Hosp Pharm; 1983 Mar; 8(1):1-13. PubMed ID: 6132928
[No Abstract] [Full Text] [Related]
3. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine: a new H2-receptor antagonist.
Berner BD; Conner CS; Sawyer DR; Siepler JK
Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
[TBL] [Abstract][Full Text] [Related]
5. [Effects of a new histamine H2-receptor antagonist, ranitidine, on experimental acute gastric and duodenal ulcers (author's transl)].
Okabe S; Kunimi H; Ohtsuki H
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):397-406. PubMed ID: 6116654
[TBL] [Abstract][Full Text] [Related]
6. Histamine H2-receptor antagonists and gastric acid secretion.
Pounder RE
Pharmacol Ther; 1984; 26(2):221-34. PubMed ID: 6152495
[No Abstract] [Full Text] [Related]
7. Comparison of ranitidine and cimetidine in the inhibition of histamine, sham-feeding, and meal-induced gastric secretion in duodenal ulcer patients.
Konturek SJ; Obtulowicz W; Kwiecien N; Sito E; Mikos E; Oleksy J
Gut; 1980 Mar; 21(3):181-6. PubMed ID: 6105116
[TBL] [Abstract][Full Text] [Related]
8. Famotidine. The ACG Committee on FDA-Related Matters with primary authorship by G. Friedman. American College of Gastroenterology.
Am J Gastroenterol; 1987 Jun; 82(6):504-6. PubMed ID: 2883885
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
Richards DA
J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
[TBL] [Abstract][Full Text] [Related]
10. [Interest of ranitidine, a new H2 receptor antagonist in the treatment of Zollinger-Ellison syndrome (author's transl)].
Mignon M; Vallot T; Mayeur S; Treffot MJ; Bonfils S
Gastroenterol Clin Biol; 1981 Jan; 5(1):42-7. PubMed ID: 6110608
[No Abstract] [Full Text] [Related]
11. [Ranitidine, a new histamine H2 receptor antagonist. First experimental and clinical data].
Simon B; Dammann HG; Müller P; Kather H
Minerva Med; 1981 Oct; 72(40):2657-61. PubMed ID: 6117040
[TBL] [Abstract][Full Text] [Related]
12. [Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results].
Simon B; Dammann HG; Müller P; Kather H
Dtsch Med Wochenschr; 1980 Dec; 105(50):1753-5. PubMed ID: 6108203
[No Abstract] [Full Text] [Related]
13. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
14. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
15. Clinical comparison of cimetidine and ranitidine.
Brater DC; Peters MN; Eshelman FN; Richardson CT
Clin Pharmacol Ther; 1982 Oct; 32(4):484-9. PubMed ID: 6288312
[TBL] [Abstract][Full Text] [Related]
16. H2-receptor antagonists: development and application.
Feldman S
N Engl Reg Allergy Proc; 1986; 7(4):362-6. PubMed ID: 2886903
[TBL] [Abstract][Full Text] [Related]
17. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
Campoli-Richards DM; Clissold SP
Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
Del Soldato P; Ghiorzi A; Cereda E; Donetti A
Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
[TBL] [Abstract][Full Text] [Related]
19. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of roxatidine acetate: a review.
Dammann HG; de Looze SM; Bender W; Labs R
Scand J Gastroenterol Suppl; 1988; 146():121-34. PubMed ID: 2906456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
